Vertex also has multiple other catalysts on the way in 2025 ... In phase 3 testing, the drug achieved around 50% reduction in ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a modest uptick, ending the day at $422 which represents a slight increase of $5.04 or 1.21% from the prior close of $416.96. The stock opened at $422.73 ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

A diagram of Nvidia's latest GB202 die has been published, showcasing Blackwell's componentry layout. A comparison to AD102 ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

During the last century, biologists have extensively studied Drosophila melanogaster, the common household fruit fly. It's ...

Finally, Vertex is actively targeting key international markets in Europe and the Asia Pacific to reach more geographies. These measures are necessary to remain the undisputed treatment provider ...

Delhi-based AI landscape automation startup Attentive AI recently closed its Series A2 funding round, bringing its total Series A funding to $12 million across two tranches (A1 and A2). The A2 round ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

MUMBAI: Founded by visionary leaders Prasad Shejale and Venugopal Ganganna, LS Digital has long been the ...